ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $365,000 | +51.5% | 3,923 | -3.1% | 0.10% | +36.4% |
| Q3 2021 | $241,000 | -10.4% | 4,048 | +2.6% | 0.08% | -7.2% |
| Q2 2021 | $269,000 | +1.5% | 3,946 | +3.3% | 0.08% | -7.8% |
| Q1 2021 | $265,000 | -9.6% | 3,820 | 0.0% | 0.09% | -14.3% |
| Q4 2020 | $293,000 | +2.4% | 3,820 | 0.0% | 0.10% | -8.7% |
| Q3 2020 | $286,000 | +19.2% | 3,820 | 0.0% | 0.12% | +7.5% |
| Q2 2020 | $240,000 | +727.6% | 3,820 | +511.2% | 0.11% | +664.3% |
| Q3 2019 | $29,000 | -21.6% | 625 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $37,000 | – | 625 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |